ResearcherUniversity of CopenhagenNo recent work listed
Emilie A. Madsen
Matched on ORCID iD 0000-0001-8903-7800; OpenAlex author ID A5006585786. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: 1 paper
Papers 2
- High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fmolb.2023.1158058↗
- Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Co-author DOI 10.3390/cells11233763↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- M.A. Karsdal · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Lars Nannestad Jørgensen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Hadi M. H. Diab · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Nicholas Willumsen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Neel Ingemann Nissen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Julia Sidenius Johansen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Carsten Palnæs Hansen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Inna Markovna Chen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Astrid Zedlitz Johansen · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.